Kimi Iguchi
Finanzdirektor/CFO bei SAGE THERAPEUTICS, INC.
Vermögen: 956 426 $ am 30.04.2024
Profil
Derzeit bekleidet Kimi E. Iguchi die Position des Chief Financial Officer & Treasurer bei SAGE Therapeutics, Inc. Frau Iguchi ist außerdem Mitglied des Vorstands von Disarm Therapeutics, Inc. Zuvor war sie Vice President-Finance bei Cyberkinetics Neurotechnology Systems, Inc., Chief Operating Officer-North America Region bei Santhera Pharmaceuticals Holding AG, Senior Manager-External Reporting bei Biogen, Inc. und Finance Manager bei Biogen MA, Inc. (eine Tochtergesellschaft von Biogen, Inc.), Senior Director-Finance, Reporting & Analysis bei Millennium Pharmaceuticals, Inc. und Manager-Business Assurance bei PricewaterhouseCoopers LLP. Frau Iguchi hat einen Undergraduate-Abschluss der Drew University und einen MBA der Northeastern University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SAGE THERAPEUTICS, INC.
0,12% | 31.03.2024 | 70 429 ( 0,12% ) | 956 426 $ | 30.04.2024 |
Aktive Positionen von Kimi Iguchi
| Unternehmen | Position | Beginn |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Finanzdirektor/CFO | 01.03.2013 |
Disarm Therapeutics, Inc.
 Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | 25.10.2018 |
Ehemalige bekannte Positionen von Kimi Iguchi
| Unternehmen | Position | Ende |
|---|---|---|
| SANTHERA PHARMACEUTICALS HOLDING AG | Corporate Officer/Principal | 01.09.2011 |
Cyberkinetics Neurotechnology Systems, Inc.
 Cyberkinetics Neurotechnology Systems, Inc. Medical SpecialtiesHealth Technology Cyberkinetics Neurotechnology Systems, Inc. manufactures medical devices. The company was founded by John Donoghue on February 6, 2002 and is headquartered in Foxborough, MA. | Finanzdirektor/CFO | 31.05.2007 |
| BIOGEN INC. | Corporate Officer/Principal | 01.01.1998 |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Corporate Officer/Principal | 01.01.1995 |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Finanzdirektor/CFO | - |
Ausbildung von Kimi Iguchi
| Drew University | Undergraduate Degree |
| Northeastern University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| SAGE THERAPEUTICS, INC. | Health Technology |
| SANTHERA PHARMACEUTICALS HOLDING AG | Health Technology |
| BIOGEN INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Cyberkinetics Neurotechnology Systems, Inc.
Cyberkinetics Neurotechnology Systems, Inc. Medical SpecialtiesHealth Technology Cyberkinetics Neurotechnology Systems, Inc. manufactures medical devices. The company was founded by John Donoghue on February 6, 2002 and is headquartered in Foxborough, MA. | Health Technology |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
Disarm Therapeutics, Inc.
Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA. | Health Technology |
